- English
- Chinese
- French
- German
- Portuguese
- Spanish
- Russian
- Japanese
- Korean
- Arabic
- Irish
- Greek
- Turkish
- Italian
- Danish
- Romanian
- Indonesian
- Czech
- Afrikaans
- Swedish
- Polish
- Basque
- Catalan
- Esperanto
- Hindi
- Lao
- Albanian
- Amharic
- Armenian
- Azerbaijani
- Belarusian
- Bengali
- Bosnian
- Bulgarian
- Cebuano
- Chichewa
- Corsican
- Croatian
- Dutch
- Estonian
- Filipino
- Finnish
- Frisian
- Galician
- Georgian
- Gujarati
- Haitian
- Hausa
- Hawaiian
- Hebrew
- Hmong
- Hungarian
- Icelandic
- Igbo
- Javanese
- Kannada
- Kazakh
- Khmer
- Kurdish
- Kyrgyz
- Latin
- Latvian
- Lithuanian
- Luxembou..
- Macedonian
- Malagasy
- Malay
- Malayalam
- Maltese
- Maori
- Marathi
- Mongolian
- Burmese
- Nepali
- Norwegian
- Pashto
- Persian
- Punjabi
- Serbian
- Sesotho
- Sinhala
- Slovak
- Slovenian
- Somali
- Samoan
- Scots Gaelic
- Shona
- Sindhi
- Sundanese
- Swahili
- Tajik
- Tamil
- Telugu
- Thai
- Ukrainian
- Urdu
- Uzbek
- Vietnamese
- Welsh
- Xhosa
- Yiddish
- Yoruba
- Zulu
- Tatar
- Oriya
- Turkmen
- Uyghur
Amakuru
-
Amakuru
Icyiciro cya 2A Kuvura Kanseri y'ibihaha 2026: Amakuru mashya ya ELCC kubijyanye no kuvura Neo-Adjuvant
Ibirimo Gusobanukirwa Icyiciro 2A Kanseri Yibihaha Ntoya Ntoya 2026 Intambwe ya ELCC mungamba za Neo-Adjuvant Ingamba zigamije kuvura abashoferi bahinduwe Icyiciro 2A Kanseri yibihaha igereranya Isesengura rya Trea ...
Kuvura kanseri y'ibihaha Indolent 2026: Porotokole nshya yo kubaho igihe kirekire
Ibirimo Gusobanukirwa Kanseri Y ibihaha Indolent muri 2026 Ihinduka rya Paradigm: Kuva Kubagwa Ako kanya Kugenzura Igikorwa Cyane Cyane Cyane cyo Kubaga Amahitamo yo Gutera Indwara Zitera Intego T ...
Kuvura kanseri y'ibihaha bidashoboka 2026: TIL nshya & Bispecific Breakthroughs
Ibirimwo Ihinduka rya Paradigm mu Kuvura Kanseri Y ibihaha Bidashoboka Gusobanukirwa Lymphocyte (TIL) Ubuvuzi Bispecific Antibodies: Uburyo bubiri-bwo kugereranya Uburyo bwo kugereranya Eme ...
Kuvura Kanseri Yibanze Yambere 2026: Amabwiriza mashya & Ubuvuzi bugezweho
Ibirimo Gusobanukirwa Kanseri Yibanze Yibanze na 2026 Ibipimo byo Gusuzuma Yavuguruwe Amabwiriza yo Kuvura Kanseri Y’ibihaha Ntoya mu iterambere rya Kanseri Ntoya yo mu micungire ya Kanseri y’ibihaha ivura ...
Kubaga Kanseri y'ibihaha 2026: Ibishya bishya bya Neo-Adjuvant
Ibirimo Ubwihindurize bwo Kubaga Kanseri Y ibihaha mu 2026 Intambwe imaze guterwa muri Immunotherapy ishingiye kuri Neo-Adjuvant Regimens igamije kuvura igenewe abashoferi-Mutation abarwayi beza ba tekinike yo kubaga ...
Amahitamo mato yo kuvura kanseri y'ibihaha 2026: Ibishya ADC & Immunotherapy
Ibirimo Gusobanukirwa nuburyo bugezweho bwa kanseri ntoya yo kuvura kanseri yibihaha Amahitamo yumurongo wa mbere: Immunotherapy Gukomatanya Kwiyongera kwa Antibody-Ibiyobyabwenge (ADCs) byibasiye DLL3: ...
